Diagnostring Laboratories
Diagnostring Laboratories offers AI-driven genomic tests to assess cancer recurrence risk in patients with benign tumors. The tests leverage AI/ML on genomic data to provide predictive insights used in clinical decision-making. Categorized as B2B healthcare analytics, the platform targets clinicians and labs seeking genomics-based risk stratification. It aims to democratize genomic healthcare by building a broad portfolio of affordable tests for widespread use. The approach aligns with India's genomic healthcare evolution, focusing on scalable AI-powered cancer prediction.
Diagnostring Laboratories
Diagnostring Laboratories offers AI-driven genomic tests to assess cancer recurrence risk in patients with benign tumors. The tests leverage AI/ML on genomic data to provide predictive insights used in clinical decision-making. Categorized as B2B healthcare analytics, the platform targets clinicians and labs seeking genomics-based risk stratification. It aims to democratize genomic healthcare by building a broad portfolio of affordable tests for widespread use. The approach aligns with India's genomic healthcare evolution, focusing on scalable AI-powered cancer prediction.